(Q38507866)

English

Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?

scientific article published on 30 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Giovanni Targher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Maurizio Rossini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

30 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

211-221

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26024975%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

https://scigraph.springernature.com/pub.10.1007/s12020-015-0640-8

0 references

From NAFLD in clinical practice to answers from guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Obesity-associated nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Hepatic histology in obese patients undergoing bariatric surgery

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Endocrine and liver interaction: the role of endocrine pathways in NASH.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Hemostatic and fibrinolytic abnormalities in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement--a survey of 12517 subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Clinical features and natural history of hepatocellular adenomas: the impact of obesity.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Prevalence of hepatic steatosis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Hepatocellular adenoma and polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Polycystic ovary syndrome: an ancient disorder?

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Hepatic steatosis and insulin resistance: does etiology make a difference?

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Mediators of chronic inflammation in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Extrahepatic complications of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Dyslipidemia in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Clinical review: Adolescent anovulation: maturational mechanisms and implications

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

HDL cholesterol efflux capacity and incident cardiovascular events

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Fatty liver, carotid disease and gallstones: a study of age-related associations

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Non-alcoholic steatohepatitis: a microbiota-driven disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Noninvasive evaluation of NAFLD.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0640-8

21 January 2018

Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoadiponectinemia is closely associated with nonalcoholic hepatic steatosis in obese subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-Grade Chronic Inflammation in Pregnant Women With Polycystic Ovary Syndrome: A Prospective Controlled Clinical Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gut microbiota and nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26024975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38507866&oldid=1588286200"